{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:09:20Z","timestamp":1785150560517,"version":"3.55.0"},"reference-count":33,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1253\/circj.cj-17-0442","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T22:09:00Z","timestamp":1504735740000},"page":"691-698","source":"Crossref","is-referenced-by-count":22,"title":["Anemia Is Associated With Blunted Response to \u03b2-Blocker Therapy Using Carvedilol\u3000\u2015 Insights From Japanese Chronic Heart Failure (J-CHF) Study \u2015"],"prefix":"10.1253","volume":"82","author":[{"given":"Yuji","family":"Nagatomo","sequence":"first","affiliation":[{"name":"Sakakibara Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Sakakibara Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Sapporo Nango Cardiovascular Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kitabatake","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Hori","sequence":"additional","affiliation":[{"name":"Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of J-CHF Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, et al. Anemia and its relationship to clinical outcome in heart failure. <i>Circulation<\/i> 2004; 110: 149\u2013154.","DOI":"10.1161\/01.CIR.0000134279.79571.73"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and mortality in heart failure patients: A systematic review and meta-analysis. <i>J Am Coll Cardiol<\/i> 2008; 52: 818\u2013827.","DOI":"10.1016\/j.jacc.2008.04.061"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Silverberg DS, Wexler D, Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. <i>Eur J Heart Fail<\/i> 2002; 4: 681\u2013686.","DOI":"10.1016\/S1388-9842(02)00115-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. <i>Eur Heart J<\/i> 2005; 26: 2232\u20132237.","DOI":"10.1093\/eurheartj\/ehi388"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kleijn L, Belonje AM, Voors AA, De Boer RA, Jaarsma T, Ghosh S, et al. Inflammation and anaemia in a broad spectrum of patients with heart failure. <i>Heart<\/i> 2012; 98: 1237\u20131241.","DOI":"10.1136\/heartjnl-2012-301954"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. <i>Circulation<\/i> 2003; 107: 226\u2013229.","DOI":"10.1161\/01.CIR.0000052623.16194.80"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. <i>J Am Coll Cardiol<\/i> 2002; 39: 1780\u20131786.","DOI":"10.1016\/S0735-1097(02)01854-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Berry C, Norrie J, Hogg K, Brett M, Stevenson K, McMurray JJ. The prevalence, nature, and importance of hematologic abnormalities in heart failure. <i>Am Heart J<\/i> 2006; 151: 1313\u20131321.","DOI":"10.1016\/j.ahj.2005.07.032"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Yokota T, Takeshita A, Yokoshiki H, et al. Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan: A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). <i>Circ J<\/i> 2009; 73: 1901\u20131908.","DOI":"10.1253\/circj.CJ-09-0184"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Okamoto H, Hori M, Matsuzaki M, Tsutsui H, Yamazaki T, Nagai R, et al. Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study. <i>Int J Cardiol<\/i> 2013; 164: 238\u2013244.","DOI":"10.1016\/j.ijcard.2012.11.051"},{"key":"11","unstructured":"11.World Health Organization. Dept. of Nutrition for Health and Development. Iron deficiency anaemia: Assessment, prevention and control: A guide for programme managers. Geneva: WHO, 2001."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. <i>Clin Exp Nephrol<\/i> 2007; 11: 41\u201350.","DOI":"10.1007\/s10157-006-0453-4"},{"key":"13","unstructured":"13.Porwit A, McCullough J, Erber WN. Blood and Bone Marrow Pathology. 2nd edn. Churchill Livingstone, 2011."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Anand IS, Kuskowski MA, Rector TS, Florea VG, Glazer RD, Hester A, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: Results from Val-HeFT. <i>Circulation<\/i> 2005; 112: 1121\u20131127.","DOI":"10.1161\/CIRCULATIONAHA.104.512988"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Varat MA, Adolph RJ, Fowler NO. Cardiovascular effects of anemia. <i>Am Heart J<\/i> 1972; 83: 415\u2013426.","DOI":"10.1016\/0002-8703(72)90445-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Franchitto N, Despas F, Labrunee M, Roncalli J, Boveda S, Galinier M, et al. Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure-related anemia. <i>Hypertension<\/i> 2010; 55: 1012\u20131017.","DOI":"10.1161\/HYPERTENSIONAHA.109.146779"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sangkatumvong S, Coates TD, Khoo MC. Abnormal autonomic cardiac response to transient hypoxia in sickle cell anemia. <i>Physiol Meas<\/i> 2008; 29: 655\u2013668.","DOI":"10.1088\/0967-3334\/29\/5\/010"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yokusoglu M, Nevruz O, Baysan O, Uzun M, Demirkol S, Avcu F, et al. The altered autonomic nervous system activity in iron deficiency anemia. <i>Tohoku J Exp Med<\/i> 2007; 212: 397\u2013402.","DOI":"10.1620\/tjem.212.397"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gold MR, Van Veldhuisen DJ, Hauptman PJ, Borggrefe M, Kubo SH, Lieberman RA, et al. Vagus nerve stimulation for the treatment of heart failure: The INOVATE-HF Trial. <i>J Am Coll Cardiol<\/i> 2016; 68: 149\u2013158.","DOI":"10.1016\/j.jacc.2016.03.525"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Goldsmith RL, Bigger JT, Bloomfield DM, Krum H, Steinman RC, Sackner-Bernstein J, et al. Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure. <i>Am J Cardiol<\/i> 1997; 80: 1101\u20131104.","DOI":"10.1016\/S0002-9149(97)00616-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Inohara T, Kohsaka S, Sato N, Kajimoto K, Keida T, Mizuno M, et al. Prognostic impact of renal dysfunction does not differ according to the clinical profiles of patients: Insight from the acute decompensated heart failure syndromes (ATTEND) registry. <i>PLoS One<\/i> 2014; 9: e105596.","DOI":"10.1371\/journal.pone.0105596"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, et al. Renal impairment and outcomes in heart failure: Systematic review and meta-analysis. <i>J Am Coll Cardiol<\/i> 2006; 47: 1987\u20131996.","DOI":"10.1016\/j.jacc.2005.11.084"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ghali JK, Wikstrand J, Van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, et al. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: Insights from Metoprolol CR\/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). <i>J Card Fail<\/i> 2009; 15: 310\u2013318.","DOI":"10.1016\/j.cardfail.2008.11.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Castagno D, Jhund PS, McMurray JJ, Lewsey JD, Erdmann E, Zannad F, et al. Improved survival with bisoprolol in patients with heart failure and renal impairment: An analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial. <i>Eur J Heart Fail<\/i> 2010; 12: 607\u2013616.","DOI":"10.1093\/eurjhf\/hfq038"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Clyne N, Hellberg M, Kouidi E, Deligiannis A, Hoglund P. Relationship between declining glomerular filtration rate and measures of cardiac and vascular autonomic neuropathy. <i>Nephrology (Carlton)<\/i> 2016; 21: 1047\u20131055.","DOI":"10.1111\/nep.12706"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Khan W, Deepak SM, Coppinger T, Waywell C, Borg A, Harper L, et al. Beta blocker treatment is associated with improvement in renal function and anaemia in patients with heart failure. <i>Heart<\/i> 2006; 92: 1856\u20131857.","DOI":"10.1136\/hrt.2005.083998"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ito H, Nagatomo Y, Kohno T, Anzai T, Meguro T, Ogawa S, et al. Differential effects of carvedilol and metoprolol on renal function in patients with heart failure. <i>Circ J<\/i> 2010; 74: 1578\u20131583.","DOI":"10.1253\/circj.CJ-09-0865"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. <i>J Pharmacol Exp Ther<\/i> 1992; 263: 92\u201398.","DOI":"10.1016\/S0022-3565(25)10363-7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, et al. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: Results from COMET. <i>Eur Heart J<\/i> 2006; 27: 1440\u20131446.","DOI":"10.1093\/eurheartj\/ehl012"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Mladenovic J, Adamson JW. Adrenergic modulation of erythropoiesis: In vitro studies of colony-forming cells in normal and polycythaemic man. <i>Br J Haematol<\/i> 1984; 56: 323\u2013332.","DOI":"10.1111\/j.1365-2141.1984.tb03959.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Albitar S, Genin R, Fen-Chong M, Serveaux MO, Bourgeon B. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. <i>Nephrol Dial Transplant<\/i> 1998; 13: 1206\u20131210.","DOI":"10.1093\/ndt\/13.5.1206"},{"key":"32","unstructured":"32. Odabas AR, Cetinkaya R, Selcuk Y, Keles S, Bilen H. The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis. <i>Panminerva Med<\/i> 2003; 45: 59\u201362."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: An observational study. <i>Lancet<\/i> 2003; 361: 1077\u20131083.","DOI":"10.1016\/S0140-6736(03)12892-9"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/3\/82_CJ-17-0442\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T16:22:13Z","timestamp":1750868533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/3\/82_CJ-17-0442\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0442","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}